Lannett Enters Into Distribution Agreement For Posaconazole Delayed-Release Tablets; Launch To Commence Shortly Read more
Machavert Pharma Signs Exclusive License Agreement to Control RAL GTPase Inhibitors against KRAS Cancers Read more
Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients Read more